69.54
前日終値:
$68.15
開ける:
$69
24時間の取引高:
5.43M
Relative Volume:
0.39
時価総額:
$103.38B
収益:
$20.08B
当期純損益:
$2.89B
株価収益率:
35.86
EPS:
1.9391
ネットキャッシュフロー:
$3.66B
1週間 パフォーマンス:
-2.50%
1か月 パフォーマンス:
-5.42%
6か月 パフォーマンス:
-29.18%
1年 パフォーマンス:
-32.58%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
69.56 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
105.39 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
327.26 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.69 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
82.44 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific: Under Pressure, But Could See A Shift In Fortunes (Rating Upgrade) - Seeking Alpha
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Is Boston Scientific Corporation (BSX) A Good Stock To Buy Now? - Insider Monkey
Boston Scientific Corp. stock shows resilient fundamentals amid volatile medtech market pressures - AD HOC NEWS
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity - TradingView
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - GlobeNewswire Inc.
Deadline Alert: Boston Scientific Corporation (BSX) - GlobeNewswire
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $90 to $120 - 富途牛牛
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - Barchart.com
Evercore ISI reiterates Boston Scientific stock rating on growth outlook - Investing.com UK
Evercore ISI reiterates Boston Scientific stock rating on growth outlook By Investing.com - Investing.com India
Stifel reiterates Boston Scientific stock rating ahead of trial data - Investing.com
Boston Scientific (BSX) Joins Evercore's Tactical Outperform Lis - GuruFocus
Boston Scientific Corporation $BSX Shares Sold by Park Avenue Securities LLC - MarketBeat
Avanza Fonder AB Acquires 21,210 Shares of Boston Scientific Corporation $BSX - MarketBeat
Robbins LLP Urges BSX Stockholders Who Lost Money Investing in Boston Scientific Corporation to Contact the Firm for Information About Leading the Class Action - Barchart.com
BSX Stock Quote Price and Forecast - CNN
ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BSX INVESTOR ALERT: Boston Scientific Corporation Investors - GlobeNewswire
Boston Scientific (NYSE:BSX) Falls as Recall Draws S&P 500 Focus - Kalkine Media
Tounjian Advisory Partners LLC Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific’s EMEA Urology Push May Reframe Valuation Story - simplywall.st
Is Boston Scientific (BSX) Still Attractive After Its Recent Share Price Pullback? - Yahoo Finance
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
Truist Cuts PT on Boston Scientific Corporation (BSX) to $92 From $95 – Here’s Why - Insider Monkey
Jim Cramer on Boston Scientific: “This Stock Was One of the Greatest Performers, It’s Not Anymore” - Insider Monkey
Needham & Company LLC Reiterates "Buy" Rating for Boston Scientific (NYSE:BSX) - MarketBeat
BOSTON SCIENTIFIC CORP ($BSX) CEO 2025 Pay Revealed - Quiver Quantitative
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
ROSEN, SKILLED TRIAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific (BSX) Faces Scrutiny Over Pacemaker Battery Re - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX) - TMX Newsfile
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming DeadlinesBSX - ChartMill
BSX DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors - GlobeNewswire Inc.
Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress? - MSN
INVESTOR ALERT: Boston Scientific Corporation Investors - GlobeNewswire
Boston Scientific Faces Investor Lawsuit Alleging Misleading Statements About Electrophysiology Growth - TipRanks
Boston Scientific (BSX) Rating Maintained, Price Target Lowered by Truist Securities | BSX Stock News - GuruFocus
Truist Financial Issues Pessimistic Forecast for Boston Scientific (NYSE:BSX) Stock Price - MarketBeat
Truist cuts Boston Scientific stock price target on valuation - Investing.com
Truist Cuts Price Target on Boston Scientific to $92 From $95, Keeps Buy Rating - marketscreener.com
Danske Bank A S Invests $94.51 Million in Boston Scientific Corporation $BSX - MarketBeat
Stance Capital LLC Grows Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
CIBC Bancorp USA Inc. Makes New $59 Million Investment in Boston Scientific Corporation $BSX - MarketBeat
Avity Investment Management Inc. Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Danica Pension Livsforsikringsaktieselskab Acquires New Position in Boston Scientific Corporation $BSX - MarketBeat
BSX Technical Analysis | Trend, Signals & Chart Patterns | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Boston Scientific (NYSE: BSX) plans 2026 virtual meeting with major governance votes - Stock Titan
Why Boston Scientific (BSX) Outpaced the Stock Market Today - Yahoo Finance
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - GuruFocus
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):